Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Olabiran

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltrationJ A Ledermann, F Pasini, Y Olabiran, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Results of the central data analysisP C Beverley, Y Olabiran, J A Ledermann, et al.
Clinical Chemistry|June 3, 1999
Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin ID J Newman, Y Olabiran, W D Bedzyk, et al.
British Journal of Cancer|February 12, 1998
Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancerD Ornadel, J A Ledermann, K Eagle, et al.
Clinical Chemistry|June 13, 1998
Development and validation of an automated latex-enhanced immunoassay for prealbuminP Holownia, D J Newman, H Thakkar, et al.
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1994
Detection of the neural cell adhesion molecule (NCAM) in serum of patients with small-cell lung cancer (SCLC) with "limited" or "extensive" disease, and bone-marrow infiltrationJ A Ledermann, F Pasini, Y Olabiran, et al.
The British Journal of Cancer. Supplement|June 1, 1991
Results of the central data analysisP C Beverley, Y Olabiran, J A Ledermann, et al.
Clinical Chemistry|June 3, 1999
Impact of antibody specificity and calibration material on the measure of agreement between methods for cardiac troponin ID J Newman, Y Olabiran, W D Bedzyk, et al.
British Journal of Cancer|February 12, 1998
Biodistribution of a radiolabelled monoclonal antibody NY3D11 recognizing the neural cell adhesion molecule in tumour xenografts and patients with small-cell lung cancerD Ornadel, J A Ledermann, K Eagle, et al.
Clinical Chemistry|June 13, 1998
Development and validation of an automated latex-enhanced immunoassay for prealbuminP Holownia, D J Newman, H Thakkar, et al.
British Journal of Cancer|February 1, 1994
The selection of antibodies for targeted therapy of small-cell lung cancer (SCLC) using a human tumour spheroid model to compare the uptake of cluster 1 and cluster w4 antibodiesY Olabiran, J A Ledermann, N J Marston, et al.
Pageof 1